Incyte_J.P.MorganSlides2025_vFINAL

2025: A Year of Defining CatalystsJ.P. Morgan Healthcare ConferenceHervé Hoppenot | January 13th, 20252Forward Looking StatementsExcept for the historical information set forth herein, the matters set forth in this presentation contain predictions, estimates and other forward-looking statements, including without limitation statements regarding: the opportunities for growth presented by Incyte’s pipeline and products; expectations regarding Incyte’s R&D and commercial execution; expected revenue contribution from near-term launches; additional label expansion opportunities; projected launches, pivotal readouts, phase 3 study initiations and proof of concept readouts; the timing of clinical trials and regulatory submissions; potential high impact launches and high impact pipeline programs; Incyte’s positioning for 2026 and beyond; and expectations regarding 2025 catalysts and newsflow items.These forward-looking statements are based on Incyte’s current expectations and subject to risks